| Ten things to know about ten cardiovascular disease risk factors HE Bays, PR Taub, E Epstein, ED Michos, RA Ferraro, AL Bailey, HM Kelli, ... American journal of preventive cardiology 5, 100149, 2021 | 144 | 2021 |
| Triglycerides and ASCVD risk reduction: recent insights and future directions A Hussain, CM Ballantyne, A Saeed, SS Virani Current atherosclerosis reports 22, 1-10, 2020 | 47 | 2020 |
| Association of NT-ProBNP, blood pressure, and cardiovascular events: the ARIC study A Hussain, W Sun, A Deswal, JA de Lemos, JW McEvoy, RC Hoogeveen, ... Journal of the American College of Cardiology 77 (5), 559-571, 2021 | 46 | 2021 |
| Zero coronary artery calcium score: desirable, but enough? A Hussain, CM Ballantyne, V Nambi Circulation 142 (10), 917-919, 2020 | 33 | 2020 |
| Non‐vitamin K oral anticoagulants versus warfarin for left atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter A Hussain, WE Katz, MV Genuardi, A Bhonsale, SK Jain, K Kancharla, ... Pacing and Clinical Electrophysiology 42 (9), 1183-1190, 2019 | 23 | 2019 |
| Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study A Hussain, C Sun, E Selvin, V Nambi, J Coresh, X Jia, CM Ballantyne, ... European journal of preventive cardiology 29 (2), e53-e64, 2022 | 22 | 2022 |
| Epidemiology and risk factors for stroke in young individuals: implications for prevention A Hussain, M Lee, J Rana, SS Virani Current opinion in cardiology 36 (5), 565-571, 2021 | 22 | 2021 |
| Highlights from studies in cardiovascular disease prevention presented at the Digital 2020 European Society of Cardiology Congress: prevention is alive and well X Jia, M Al Rifai, A Hussain, S Martin, A Agarwala, SS Virani Current atherosclerosis reports 22, 1-9, 2020 | 22 | 2020 |
| Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure JA Chirinos, M Sardana, G Oldland, B Ansari, J Lee, A Hussain, A Mustafa, ... ESC Heart Failure 5 (5), 911-919, 2018 | 22* | 2018 |
| 2022 ACC expert consensus decision pathway for integrating atherosclerotic cardiovascular disease and multimorbidity treatment: a framework for pragmatic, patient-centered care … Writing Committee, KK Birtcher, LA Allen, JL Anderson, MP Bonaca, ... Journal of the American College of Cardiology 81 (3), 292-317, 2023 | 20 | 2023 |
| Genetic testing in ambulatory cardiology clinics reveals high rate of findings with clinical management implications DR Murdock, E Venner, DM Muzny, GA Metcalf, M Murugan, TD Hadley, ... Genetics in Medicine 23 (12), 2404-2414, 2021 | 18 | 2021 |
| Premature atherosclerotic cardiovascular disease risk among patients with inflammatory bowel disease MT Lee, D Mahtta, L Chen, A Hussain, M Al Rifai, P Sinh, U Khalid, ... The American Journal of Medicine 134 (8), 1047-1051. e2, 2021 | 18 | 2021 |
| New approaches for the prevention and treatment of cardiovascular disease: focus on lipoproteins and inflammation A Hussain, CM Ballantyne Annual review of medicine 72, 431-446, 2021 | 14 | 2021 |
| Cluster randomized trial examining the impact of automated best practice alert on rates of implantable defibrillator therapy J Lee, L Szeto, DK Pasupula, A Hussain, A Waheed, S Adhikari, ... Circulation: Cardiovascular Quality and Outcomes 12 (6), e005024, 2019 | 14 | 2019 |
| Oral anticoagulation and left atrial thrombi resolution in nonrheumatic atrial fibrillation or flutter: A systematic review and meta‐analysis NC Wang, MD Sather, A Hussain, AD Althouse, EC Adelstein, SK Jain, ... Pacing and Clinical Electrophysiology 41 (7), 767-774, 2018 | 13 | 2018 |
| Utilization rates of SGLT2 inhibitors among patients with type 2 diabetes, heart failure, and atherosclerotic cardiovascular disease: insights from the Department of Veterans … A Hussain, D Ramsey, M Lee, D Mahtta, MS Khan, V Nambi, ... Heart Failure 11 (8_Part_1), 933-942, 2023 | 12 | 2023 |
| Soluble angiotensin-converting enzyme 2, cardiac biomarkers, structure, and function, and cardiovascular events (from the atherosclerosis risk in communities study) A Hussain, O Tang, C Sun, X Jia, E Selvin, V Nambi, A Folsom, G Heiss, ... The American journal of cardiology 146, 15-21, 2021 | 12 | 2021 |
| Social determinants of health and comorbidities among individuals with atherosclerotic cardiovascular disease: the behavioral risk factor surveillance system survey M Al Rifai, X Jia, J Pickett, A Hussain, SD Navaneethan, KK Birtcher, ... Population health management 25 (1), 39-45, 2022 | 11 | 2022 |
| Endpoints in heart failure drug development A Hussain, A Misra, B Bozkurt Cardiac Failure Review 8, 2022 | 11 | 2022 |
| Racial disparities in modifiable risk factors and statin usage in black patients with familial hypercholesterolemia A Agarwala, N Bekele, E Deych, MW Rich, A Hussain, LK Jones, ... Journal of the American Heart Association 10 (17), e020890, 2021 | 10 | 2021 |
